PRODEO is a streetwise brain health executive group. PRODEO is continuously engaged with the latest science, investment activity, market dynamics, policy trends, diplomacy, healthcare delivery systems, payors, consumer demands, philanthropy, as well as the most influential organizations in the field. PRODEO curates and converges novel, proven and emerging technologies relevant to brain health. These include genomics, multi-omics, augmented reality, biometrics, affective computing and the gut-brain-axis. The span of brain health includes brain injury, neurodegenerative, neurodevelopmental and neuropsychiatric disorders. PRODEO is associated with The PRODEO Institute, which seeks radical advances in brain health - driven by a closer integration of diverse disciplines and sectors.